HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 4.410
-0.030 (-0.68%)
Nov 6, 2026, 4:00 PM EST
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 134.25 million as of November 6, 2026. It is the 25,189th most valuable company in the world and the 664th biggest in Canada. Its market cap has decreased by 20.66% in one year.
Market Cap
134.25M
Enterprise Value
174.26M
Revenue
79.87M
Global Rank
Country Rank
#664 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 134.25M, a decrease of -57.77%. That is a compound annual growth rate of -9.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 134.25M | -10.94% |
| Dec 31, 2025 | 150.74M | 20.64% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 222.61M |
| Cannara Biotech | 202.37M |
| BioSyent | 193.95M |
| Organigram Global | 188.95M |
| Cardiol Therapeutics | 168.22M |
| Medexus Pharmaceuticals | 158.39M |
| Grown Rogue International | 127.47M |
| Ascend Wellness Holdings | 110.69M |